Aspect Medical Systems
This article was originally published in The Gray Sheet
Executive SummaryNegotiates venture financing of approximately $8.3 mil. Harvard Management Company's Aeneas Group will provide funds, as will current investors Merrill Pickard Anderson & Eyre, New Enterprise Associates, Catalyst Ventures, Mayfield Fund and Sutter Hill Ventures. Upon completion of the transaction, Aeneas Vice President Marc Silver will become the seventh member of Framingham, Massachusetts-based Aspect's board. Proceeds will be used for sales expansion, for marketing and manufacturing operations and to "accelerate certain research and development efforts," according to the firm. Aspect began shipments of its first product, the A-1000 electroencephalographic (EEG) monitor, this month. The firm also is conducting trials to support a PMA application for an anesthesia monitoring system.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.